Vanguard Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-905,343
| Closed | -$119M | – | 4369 |
|
|
2020
Q4 | $119M | Buy |
905,343
+175,188
| +24% | +$23.1M | ﹤0.01% | 1746 |
|
|
2020
Q3 | $36.9M | Buy |
730,155
+34,903
| +5% | +$1.76M | ﹤0.01% | 2166 |
|
|
2020
Q2 | $33.1M | Buy |
695,252
+251,429
| +57% | +$12M | ﹤0.01% | 2198 |
|
|
2020
Q1 | $21.7M | Buy |
443,823
+41,682
| +10% | +$2.04M | ﹤0.01% | 2245 |
|
|
2019
Q4 | $23.1M | Buy |
402,141
+75,858
| +23% | +$4.35M | ﹤0.01% | 2463 |
|
|
2019
Q3 | $11.7M | Sell |
326,283
-49,895
| -13% | -$1.79M | ﹤0.01% | 2732 |
|
|
2019
Q2 | $11.7M | Buy |
376,178
+11,857
| +3% | +$369K | ﹤0.01% | 2774 |
|
|
2019
Q1 | $8.54M | Buy |
364,321
+108,720
| +43% | +$2.55M | ﹤0.01% | 2912 |
|
|
2018
Q4 | $3.52M | Buy |
255,601
+56,928
| +29% | +$783K | ﹤0.01% | 3203 |
|
|
2018
Q3 | $1.98M | Buy |
198,673
+148,673
| +297% | +$1.48M | ﹤0.01% | 3533 |
|
|
2018
Q2 | $1.02M | Buy |
+50,000
| New | +$1.02M | ﹤0.01% | 3682 |
|